goserelin and Muscle-Weakness

goserelin has been researched along with Muscle-Weakness* in 2 studies

Other Studies

2 other study(ies) available for goserelin and Muscle-Weakness

Article	Year
Goserelin cannot improve the weakness of a patient with kennedy disease after 40-week administration. CNS neuroscience & therapeutics, 2012, Volume: 18, Issue:12 Topics: Adult; Antineoplastic Agents, Hormonal; Bulbo-Spinal Atrophy, X-Linked; Fatigue; Goserelin; Humans; Male; Muscle Weakness; Receptors, Androgen; Treatment Failure; Trinucleotide Repeat Expansion	2012
Central pain and complex motoric symptoms after gosarelin therapy of prostate cancer. TheScientificWorldJournal, 2004, Nov-18, Volume: 4 A 76-year-old man with prostate cancer T3N0M0 and increasing PSA was treated with goserelin three times in a half year. As soon as the first treatment, he described subjective muscle weakness. After the third treatment, he developed complex motoric symptoms and atypical central pain with a likely association to goserelin. His left arm had signs of spastic movement; pain deteriorated after relaxation. The right hand showed muscle cramps under passive movements of the left arm that were not typical for rigor. He felt aching and partial burning pain in his whole body. There were few allodynic areas, mainly in the left arm. Several treatment approaches failed and the patient died some weeks after the first contact with our pain clinic due to pneumonia. Topics: Aged; Dyskinesia, Drug-Induced; Fatal Outcome; Goserelin; Humans; Male; Muscle Weakness; Pain; Prostatic Neoplasms	2004

Article

Year

Goserelin cannot improve the weakness of a patient with kennedy disease after 40-week administration.

CNS neuroscience & therapeutics, 2012, Volume: 18, Issue:12

Topics: Adult; Antineoplastic Agents, Hormonal; Bulbo-Spinal Atrophy, X-Linked; Fatigue; Goserelin; Humans; Male; Muscle Weakness; Receptors, Androgen; Treatment Failure; Trinucleotide Repeat Expansion

2012

Central pain and complex motoric symptoms after gosarelin therapy of prostate cancer.

TheScientificWorldJournal, 2004, Nov-18, Volume: 4

A 76-year-old man with prostate cancer T3N0M0 and increasing PSA was treated with goserelin three times in a half year. As soon as the first treatment, he described subjective muscle weakness. After the third treatment, he developed complex motoric symptoms and atypical central pain with a likely association to goserelin. His left arm had signs of spastic movement; pain deteriorated after relaxation. The right hand showed muscle cramps under passive movements of the left arm that were not typical for rigor. He felt aching and partial burning pain in his whole body. There were few allodynic areas, mainly in the left arm. Several treatment approaches failed and the patient died some weeks after the first contact with our pain clinic due to pneumonia.

Topics: Aged; Dyskinesia, Drug-Induced; Fatal Outcome; Goserelin; Humans; Male; Muscle Weakness; Pain; Prostatic Neoplasms

2004